This study looks at how well standard chemotherapy and a medication called bevacizumab work together with or without another medicine called INCA33890. It focuses on the first treatment for patients with advanced colorectal cancer that is not easily treatable with surgery. The goal is to find out how effective and safe these treatments are for patients.
The trial's ID is NCT07284849. This is a Phase 3 trial, which means it is looking at how well the treatments work and how safe they are. The study is regulated by the FDA and aims to include about 700 participants.
Who can join
Adults 18 years and older can join. This trial is open to men and women with stage IV colorectal cancer that cannot be surgically removed. Participants must not have had previous treatment for their cancer. The study team will check to see if candidates meet all other eligibility requirements.
Condition
CRC (Colorectal Cancer)
Age group
Adult, Older adult
Sex
All sexes
The study team makes the final call on eligibility.
What happens in the study
Participants will be placed into two groups by chance. One group will receive INCA33890 along with bevacizumab and FOLFOX chemotherapy. The other group will receive a placebo (a non-active treatment) along with the same chemotherapy and bevacizumab. Everyone will receive either the treatment or the placebo as part of the study.
Where
This trial is enrolling at 80 locations. Recruiting sites are listed first.
Alliance Cancer Specialists
Doylestown, Pennsylvania
Recruiting
Cancer Care Associates of York
York, Pennsylvania
Recruiting
Cancer Center For Blood Disorders A Division of American Oncology Partners P.A
Treats pancreatic cancer, lung cancer and colorectal cancer. The main cancer doctor for adults. Manages your treatment and your care team. Recognized at state, national or international level.
Directs genitourinary oncology at Huntsman Cancer Institute. Treats pancreatic cancer, liver cancer, gallbladder cancer and esophageal cancer. Also treats stomach cancer and colorectal cancer.
Treats colorectal cancer. Offers minimally invasive surgery, laparoscopic surgery and robotic surgery. A surgeon is the doctor who removes cancer with an operation (adults). Recognized at state, national or international level.